Summary
For Year 2026-27, Krsnaa Diagnostics reports the following shareholding: Total Promoters at 27.11%, Mutual Fund at 10.17%, Insurance at 2.67%, Foreign Institutional Investors at 3.91%, Domestic Institutional Investors at 1.05%, and Retail at 55.08%. This breakdown provides a quick snapshot of ownership distribution for Krsnaa Diagnostics in 2026-27.
Krsnaa Diagnostics FAQs
As of 04-2026, the promoter shareholding in Krsnaa Diagnostics stands at 27.11% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Krsnaa Diagnostics is 3.91% and 1.05% respectively.
The retail shareholding of the Krsnaa Diagnostics is 55.08%.
Changes in shareholding patterns of Krsnaa Diagnostics can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Krsnaa Diagnostics are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Krsnaa Diagnostics Associated Pages
